Literature DB >> 10996985

Prevalence of hepatitis C virus (HCV) infection and its vertical transmission in Egyptian pregnant women and their newborns.

A S Kassem1, A A el-Nawawy, M N Massoud, S Y el-Nazar, E M Sobhi.   

Abstract

We studied the prevalence of hepatitis C virus (HCV) antibody seropositivity using ELISA (Ortho Diagnostic system, 3rd generation test) polymerase chain reaction testing of HCV-RNA (PCR, Promega) and serum alanine transferase (ALT) level in 100 healthy, HIV-negative, pregnant women who delivered spontaneously at the Alexandria University Hospital, and their newborns. Some risk factors were studied using Fisher's exact test. Nineteen per cent of pregnant women were HCV seropositive and 14 of them (14/19) had circulating HCV-RNA, detected by PCR. Nine of the babies born to the 19 HCV seropositive females had circulating antibodies, whereas HCV-RNA was detected in five of them. This gives a vertical transmission risk of 5/14 (36 per cent) for mothers carrying the HCV-RNA and 5/19 (26 per cent) for those having circulating HCV antibodies. History of previous blood transfusion, elevated serum ALT level, and history of infection with schistosomiasis were significant risk factors for HCV infection in mothers. In addition to the previous factors, maternal history of jaundice, stillbirth and hepatomegaly were significant risk factors for neonatal infection. The occurrence of early jaundice and the presence of congenital anomalies in the newborns were non-significant risk factors. In conclusion, our data indicate a high prevalence of HCV seropositivity in Egyptian HIV-negative pregnant women with a significant high rate of vertical transmission of HCV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996985     DOI: 10.1093/tropej/46.4.231

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  8 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Rapid screening for co-infection of HIV and HCV in pregnant women in Benin City, Edo State, Nigeria.

Authors:  M U Duru; H S A Aluyi; K C Anukam
Journal:  Afr Health Sci       Date:  2009-09       Impact factor: 0.927

3.  Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants.

Authors:  Khaled AbdulQawi; Ahmed Youssef; Mohamed A Metwally; Ibrahim Ragih; Mohamed AbdulHamid; AbdulAziz Shaheen
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

Review 4.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

5.  Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran.

Authors:  Seyed Reza Mohebbi; Azar Sanati; Kourosh Cheraghipour; Mohammad Rostami Nejad; Hamid Mohaghegh Shalmani; Mohammad Reza Zali
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

Review 6.  Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.

Authors:  Manale Harfouche; Hiam Chemaitelly; Silva P Kouyoumjian; Sarwat Mahmud; Karima Chaabna; Zaina Al-Kanaani; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

7.  Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications.

Authors:  Diego F Cuadros; Adam J Branscum; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  Hepatology       Date:  2014-08-19       Impact factor: 17.425

Review 8.  Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.

Authors:  Silva P Kouyoumjian; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.